Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity
<p>Abstract</p> <p>Background</p> <p>Two component lantibiotics, such as the plasmid-encoded lacticin 3147 produced by <it>Lactococcus lactis </it>DPC3147 and staphylococcin C55 produced by <it>Staphylococcus aureus </it>C55, represent an emergin...
Main Authors: | O'Sullivan Orla, O'Connor Paula, Cotter Paul D, O'Connor Eileen B, Tagg John R, Ross R Paul, Hill Colin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-04-01
|
Series: | BMC Microbiology |
Online Access: | http://www.biomedcentral.com/1471-2180/7/24 |
Similar Items
-
Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147
by: Crispie Fiona, et al.
Published: (2004-11-01) -
<it>In silico </it>analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria
by: Ross R Paul, et al.
Published: (2010-11-01) -
Bioengineering lantibiotics for therapeutic success
by: Des eField, et al.
Published: (2015-11-01) -
Bactofencin A, a New Type of Cationic Bacteriocin with Unusual Immunity
by: Eileen F. O'Shea, et al.
Published: (2013-12-01) -
Comprehensive Approaches for the Search and Characterization of Staphylococcins
by: Rosa Fernández-Fernández, et al.
Published: (2023-05-01)